Contact Home



Target Audience
The conference is designed for nurses and other health care professionals interested in recent developments in the field of pediatric endocrinology nursing, including pediatric diabetes.

Program Goals
It is PENS’ goal to promote high quality endocrinology nursing practice through this educational offering. Conference participants receive the latest information in basic to advanced practice, experience and research as demonstrated by pediatric endocrinologists and pediatric endocrinology nurses.
Program Objectives​
  • Develop new skills to improve educational and patient outcomes
  • Provide educational opportunities in pediatric endocrinology for nurses and others with expertise in the area
  • Promote the pursuit of nursing practice and research through a research presentation and poster session
  • Provide educational opportunities in the management and treatment of selected endocrine disorders
  • Provide direction for understanding health care changes
PENS Conference Planning Committee
Sheri L. Luke, MSN, FNP-C, Chair
Leigh Pughe, RN, MS, CPNP, Vice Chair
Jane Torkelson, MS, RN
Josie Hong, BSN, RN
Christin Morell, RN, BSN
Amanda Patterson, BSN, RN
Catherine Flynn, RN, MSN, APRN, CDE, Board Liaison

This activity will be submitted to the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91).

The opportunity to develop and continue relationships with your colleagues through networking is one of the key benefits of attending the PENS Conference. Networking offers many tangible benefits to conference participants, including, but not limited to, validating your experience in providing nursing care and developing a better understanding of your practice and your role in care delivery by learning from others who are dealing with similar circumstances, solving the same problems and confronting the same issues. Take advantage of this national gathering of pediatric endocrinology nurses to learn more about national issues and trends.​​

PENS is providing a venue for meeting attendees to view and discuss participants’ poster presentations on Thursday evening. Visit with the poster presenters and learn about current research that will affect your clinical practice!

​​Monday, November 2, 2020
Time ​Presentation/Event Prese​nter(s)
​12:30 p.m. - 4:3​0 p.​m.
3.75 Contact Hours​*
​Pre-Conference Workshop
Evidence to Practice: Preparing Kids with Chronic Endocrine Health Conditions to Care for Themselves
This pre-conference brings together all of us to explore the problem of transition while learning evidence-based practice skills in this interactive, fun workshop. We will gather, appraise, and synthesize evidence to find collaborative solutions that can be used with the children we see every day.  Each of us will bring our experience and expertise as we discuss transition, an issue that is central to all of our practices.

PENS 2019 workshop comments and why we are doing another!
  • Loved the hands on practice! Would have loved another hour to discuss clinical challenges and potential future studies.
  • This was an excellent session! I was happily surprised that what I considered to be “dry” content was presented in a fun way with lots of active participation along with the information!
  • Great session!
  • This was one of the best sessions at the conference. I loved the hands on work and the specificity of the topics.
  • Excellent session that provided great information about conducting all aspects of EBP. I especially liked the hands on work with evaluating strength of journal articles. It was nice to discuss as a group and with an expert to improve my depth of reading and evaluation in the future
  • This pre-conference workshop was amazing. Carol, Sharron, and Terri did an excellent job. The workshop was informative and interactive, I greatly benefited from this.
​​Terri Lipman, PhD, CRNP, FAAN
Sharron Close, PhD, MS, CPNP-PC, FAAN
Carol Howe, PhD, RN, CDE, FAAN

12:30 p.m. - 4:3​0 p.​m. ​Pre-Conference Workshop 2
T1D & Me Program: Learn about an Educational Resource for Children with T1 and Their Caregivers

Being diagnosed with type 1 diabetes may be overwhelming at times. Even when providers do their best to explain the diagnosis and treatments, many young patients and their parents are left wondering how they will be able to successfully manage living with the disease. Families of recently diagnosed children are mindful of keeping blood sugar levels in range, coping with blood testing and injections, deciding on which foods to eat, and just managing everyday life. In many cases, the learning curve can feel overwhelming and leave the families with “information overload.”

To help with this problem, the T1D and Me Program has been developed by Novo Nordisk in partnership with JDRF. Using the proven Conversation Map® model, the program aims to find new and better ways to impart knowledge and build confidence in the early stages of life after diagnosis. Designed with group facilitation in mind, the program has been granted a favorable review by the AADE and can be customized to work in any pediatric diabetes treatment setting.

Join this workshop to be trained on implementation for your center, and to order your free facilitation kit. 

4:30 p.m. - 5:30 p.m. ​New Member/First Time Attendee Orientation & Past Presidents Reception​
5:30 p.m. - 7:30 p.m. ​Welcome Reception in Exhibit Hall
Refreshments and Appetizers Provided

Tuesday, November 3, 2020​​​​​​
Time Presentation​/Event Presenter(s)
​7:00 a.m. - 8:00 a.m.Ultragenyx Breakfast Symposium: X-Linked Hypophosphatemia – Cases of Diagnosis and Management
Breakfast Buffet Provided 
A case-based presentation of patients with X-Linked Hypophosphatemia describing path toward diagnosis and disease management.
Margo Black, MSN, RN, CCRP, Vanderbilt University Medical Center, Nashville, TN
8:00 a.m. - 8:15 a.m.Welcome & Opening RemarksCatherine Flynn, RN, MSN, APRN, CDE​
​8:15 a.m. - 9:15 a.m.
1.0 Contact Hour*
Keynote Address
Laugh to the Top – A Hilarious Guide to Achieving Your Goals

​This highly entertaining, thought-provoking presentation is packed with practical, proven techniques for setting, pursuing, and achieving both professional and personal goals, and will inspire attendees to attack their objectives with renewed vigor, determination, and focus. In his Seven-Step Guide--from Controlling Stress to Identifying a Specific Target to Taking Bold Action--Mack dramatically demonstrates how far diligent baby steps can take you, how to maintain a positive attitude and sense of humor during the direst of circumstances, and how to dissolve that knot of fear when you’re venturing into unknown and frightening new territory. The audience will listen, mesmerized by the message and Mack’s magical stage presence, they’ll laugh, and they’ll learn that nothing can prevent them from making themselves and their organizations the very best that they can be.

​Mack Dryden
9:15 a.m. - 10:15 a.m.
1.0 Contact Hour*
​General Session 1 
Newborn Screening for Adrenoleukodystrophy: Monitoring for and Treatment of Adrenal Insufficiency

Adrenoleukodystrophy is a peroxisomal disorder with varying clinical presentations, variably affecting the adrenal glands, nervous system, and testicular function. New York State started screening for adrenoleukodystrophy (ALD) on the newborn screening panel on December 30, 2013.  Since that time, it has expanded to 14 states, with many states mobilizing efforts to add it to their screening panels after ALD was added to the Recommended Uniform Screening Panel in 2016.  Initial experience with early onset adrenal insufficiency led the Pediatric Endocrine Society to publish guidance for monitoring newborn males with ALD, and recent publications have suggested adrenal insufficiency is present in the vast majority of males with ALD. 

Molly O. Regelmann, MD
10:15 a.m. - 10:45 a.m. ​Refreshment Break in Exhibit Hall
Coffee, Tea, Water and Soft Drinks Provided 
10:45 a.m. - 11:45 a.m.
1.0 Contact Hour*
​General Session 2 
TransCon Technology: The New Paradigm Shift for the Treatment of Unmet Medical Need – TransCon hGH, TransCon PTH, and TransCon CNP

TransCon technology provides the paradigm shift of long-acting medication to achieve unmet medical need. The Phase 3 heiGHt trial demonstrated TransCon hGH had superior efficacy, as well as comparable safety and tolerability to daily growth hormone. It is believed that these results provide a validation of the TransCon technology platform, which forms the basis of the endocrinology pipeline, which includes TransCon PTH for hypoparathyroidism and TransCon CNP for achondroplasia. This presentation will be helpful for practitioners in the field of pediatric endocrinology.  

Pisit Pitukcheewanont (Dr. Duke), MD, FAAP
11:45 a.m. - 12:45 p.m.
1.0 Contact Hour*
​General Session 3
Type 2 Diabetes in Children

Dr. de la Torre will cover the following objectives, and more, in his presentation. 
  • Discuss the characteristics of children and adolescents with Type 2 diabetes.
  • Identify who should be screened for pre-diabetes and Type 2 diabetes.
  • Discuss diagnostic criteria for diabetes and the classification of Type 2 diabetes.
  • Identify current treatment goals and options for children and adolescents with Type 2 diabetes.
Alejandro de la Torre, MD
12:45 p.m. - 2:15 p.m. ​Lunch with Exhibitors & Product Theaters
Boxed Lunches Provided
2:15 p.m. - 3:15 p.m.
1.0 Contact Hour*
​Concurrent Session 1

1A: Diabetes Case Studies​

Case Study 1: Medication-Induced Hyperglycemia – Can Acute Pancreatitis Cause Long-Term, Insulin-Dependent Diabetes Mellitus?
This case presentation compares two patients with oncologic diagnoses that developed unique secondary diabetes due to peg-aspariginase chemotherapy. Despite varying presentations, both patients likely developed pancreatitis secondary to chemotherapy, resulting in diabetes mellitus with long-term insulin requirements. While steroid-induced diabetes is transient, asparaginase-associated diabetes can be indefinite. Diabetes as a result of pancreatic injury can be difficult to diagnose and challenging to manage. Endocrine NPs are vital in providing follow-up care to patients with unique etiologies of diabetes and must maintain awareness of the potential sequalae that different medications can have on the pancreas. As the incidence of childhood leukemia and lymphoma are on the rise, it is important for PENS nurses to understand how to work with this unique diabetes population in the setting of associated comorbidities. Current research regarding peg-asparaginase-related diabetes is limited, and there are no current guidelines for best practice.

Case Study 2: Breakdown in Communication – How Lapse of Teamwork Can Delay Management of T1DM
As one of the 2019 Joint Commission Patient Safety Goals, communication is an imperative pillar to our practice as endocrine providers. The presenters aim to use a case study to highlight the importance of effective collaboration and highlight areas of potential breakdown to prevent patient harm moving forward. While a widely researched topic, this discussion aims to ignite a personal connection to the issue, leading to deeper thought about the provider’s home center and ways that they can help improve systems around the diagnosis and management of Diabetes Mellitus. This case study will assist participants to creatively explore ways to educate colleagues and establish trusting relationships that ultimately improve patient outcomes.

Case Study 3: Water – Is There Really Such a Thing as Too Much?
The presenter will provide two case studies. Case 1 is a patient with polydipsia and a strong family history of DM. Case 2 is a Type 1 DM patient with polydipsia. The presenter will cover the concern for possible Wolfram syndrome, discuss polydipsia and the possibility for DI and how to work-up, review the meaning of labs, and decision making.  The presenter will also lead a brief discussion of Wolfram syndrome. Polydipsia is a symptom of not only DM but DI as well, so even those who don't see DM patients will benefit from this discussion.

Michelle Marowitz, RN, CRNP, PNP; Elizabeth Boyce, RN, CRNP

Michelle Marowitz, RN, CRNP, PNP; Elizabeth Boyce, RN, CPNP

Cheryl Switzer, MSN, RN, CPNP, CDE​; Faith Poprik, RN, MSN, FNP-BC

​1B: The Diabetes Team: What Are We Doing Wrong?​

The purpose of this topic is to motivate the participants to think about the utilization of an innovative team when caring for vulnerable children and families – using a randomized controlled study as an exemplar.

Terri Lipman, PhD, CRNP, FAAN
​1C: Writing for Publication
This presentation will focus on the following objectives:
  • Discuss the knowledge and skills necessary for writing for newsletters, journals, and other nursing related publications.
  • Identify a potential topic for publication based on your area of clinical expertise.
  • Identify potential organizational resources within the work setting that can be accessed to achieve your publication goal.
​Cecily Betz, PhD, RN, FAAN
Carol Howe, PhD, RN, CDE, FAAN
​3:15 p.m. - 3:45 p.m. Refreshment ​Break in Exhibit Hall
Coffee, Tea, Water and Soft Drinks Provided 
3:45 p.m. - 4:45 p.m.
1.0 Contact Hour*
​Concurrent Session 2
​2A: Adrenal Insufficiency Emergency Management

​Molly Regelmann, MD

​2B: Growing Pains: The First Two Years of Building a Pediatric Transgender Center

Building a new clinic from the ground up without much precedent to go off of was very challenging.  We would like to take what we have learned and share it with others in hopes of making it easier for other medical centers to build their own programs.  The CDC published recently that 1.8-2% of high school students in the U.S. identify as transgender, and we have seen our clinic grow from 38 patients to over 500 in two short years.  This type of clinic is providing an unmet need for an underserved population in the community and it can bring increased visibility to medical centers.

Karen Hamon, BSN, RN
Casey Lofquest, MSN, BSN, CPNP
Jamie Reed, BA, CM
​2C: Weighing in on Children with Autism: Barriers and Strategies for Successful Weight Management

Children on the autism spectrum face numerous daily challenges based on the characteristics associated with autism. This attributes of rigidity, need for routine, and sensory defensiveness often contribute to selective eating patterns and preferences for calorically dense foods. Consequently, the development of persistent abnormal eating behaviors likely contributes to the development of feeding and weight concerns in children with Autism. The prevalence of overweight/obesity in children with autism is between 14.8% and 23 %, and can be as high as 30% for children with behavioral concerns on atypical psychotic medication. Rates are higher than typically developing children. This presentation will address common barriers to successful weight management as identified by parents and providers. Through case presentations, we will brainstorm strategies to address these barriers and discuss intervention to decrease risk for long-term comorbidities, including type 2 Diabetes. Weight management is tricky for many and is even more challenging for children with autism.

Goldie Markowitz, MSN, CRNP
Marianne Buzby, MSN, CRNP​
4:50 p.m. - 5:50 p.m.
1.0 Contact Hour*
​Concurrent Session 3

3A: ​Success in School with Type 1 Diabetes
A phrase that I've used often throughout this proposal is "bridging the gap". That's exactly what I want to do here--bridge the gap between healthcare provider, parent, school healthcare provider, and ultimately, student, in order to promote success and independence with a chronic condition. I have a unique perspective--not only as a worker in the school and provider settings--but also as someone who has lived well with type 1 diabetes for the last 36 years. I can provide scenarios from actual students and families for attendees to brainstorm ideas for how to be a team player in promoting growth and success in families living with type 1 diabetes.


Cassandra Moffitt, BSN, RN, CDE
​3B: Aiding Medical Providers of Teens with Type 1 Diabetes Mellitus (T1DM): Tools to Manage Stress 
The goals of this session include 1) review a complex case of an adolescent with T1DM with significant non-adherence and mental health issues, 2) provide a framework for understanding similar patient presentations and the impact on those providing medical care, and 3) conduct small group discussion to explore concrete coping strategies for medical providers.  Attendees will leave with ideas and strategies to manage daily stress around caring for this population.​
Kristine Welsh, MSN, APRN
Julia Price, PhD

​3C: Navigating the Growth Hormone Appeal Process: Perspectives by Patient Advocate and Nursing

Provide tactics in minimizing denials  Promote awareness of growth impaired children and their inability to obtain medication due to payor exclusions and criteria  Utilization of resources pertinent to appeal process    Denials for growth impaired children are on the rise dramatically due to the PES consensus guidelines; we will discuss current trends and potential solutions to assist the nursing community in gaining access for patient medications.

Fran Waite, RN​
Tamara Nenadovich, RN​

6:00 p.m. - 7:15 p.m.
1.25 Contact Hours*
​Poster Reception​
Research Posters Presented by Authors
7:30 p.m. - 10:00 p.m. Networking Night - On Your Own
Wednesday, November 4, 2020​
​​Time Presentation​/Event​ Presenter(s)
8:00 a.m. - 9:00 a.m. Abbvie Breakfast Symposium: Overcoming challenges with Diagnosing, Treating, Monitoring, and Discontinuing Therapy in patients with Central Precocious Puberty using Case Studies

Dr. Klein will utilize several case studies to discuss challenges in diagnosis, treatment, monitoring, and discontinuing therapy and how to overcome them. Dr. Klein will also share current and updated clinical data from Lupron Depot-PED’s long-term clinical data discussing efficacy, safety, and long term growth and fertility outcomes. Dr. Klein will also share AbbVie’s patient support resources to help families facing Central Precocious Puberty.         

Karen Oerter Klein, MD
9:00 a.m. - 10:00 a.m.
1.0 Contact Hour*
​General Session 4 
Oral Abstract Presentations 

Understanding Parental Beliefs and Practices toward Sugar-Sweetened Beverage Consumption in Their Young Children

The Influence of Social Determinants of Health on Family and Self-management of Type 1 Diabetes in Black, Single-Parent Families

Angela Northrup, PhD, RN, FNP; Christen Cupples Cooper, EdD, RDN

Jennifer Morone, MA-ATR, BS-RN
10:00 a.m. - 10:15 a.m. Refreshment Break
Coffee, Tea, Water and Soft Drinks Provided 
10:15 a.m. - 11:15 a.m.
1.0 Contact Hour*
​General Session 5 
Hypoglycemia Evaluation in the Endocrine Clinic
This session will be interactive and cover the underlying physiology of hypoglycemia, the common causes of hypoglycemia seen in the outpatient department, and the diagnosis and management of some of the more specific disorders.
Paul Thornton, MD​
11:25 a.m. - 12:25 p.m.
1.0 Contact Hour*
Concurrent Session 4​:
​4A:  Endocrine Overview Part 1 

This session is geared to the new nurse and will cover Endocrine Basics with an emphasis on:
  • Hypothalamic-Pituitary Portal System,
  • Pituitary hormone secretion disorders,
  • Overview of normal puberty and associated disorders, and
  • Thyroid hormone secretion function and disorders.

Fran Waite, RN

​​ ​4B: Growth Failure:  Examine Case Studies, Determine Causes, Discuss Solutions

Growth failure is a common cause for referral to Pediatric Endocrinology, with a wide variety of etiologies, not always treated with growth hormone.  The primary objective of this presentation is to utilize case studies to explore three different causes of growth failure, including pathophysiology that precipitates growth failure, iatrogenic causes of growth failure, and psychosocial obstacles that induce growth failure and prevent appropriate, timely treatment.  This presentation, intended for all Pediatric Endocrinology nurses, will include power point and lecture, but a primary educational opportunity will be to allow participation by attendees in small and large group discussion to determine solutions to questions and issues posed throughout the case studies.  This session will be a different, fun way to examine growth problems in children and share possible solutions.

​​Linda Steinkrauss, RN, MSN, CPNP
12:30 p.m. - 2:00 p.m. ​Awards Lunch and Membership Meeting
Lunch Buffet Provided
2:00 p.m. - 3:00 p.m.
1.0 Contact Hour*
Concurrent Session 5:
​5A:  Writing the Roller Coasters: Writing for Health​

Writing is health supportive. It impacts our physical, emotional and cognitive being.  Writing letters, notes, journal entries and poetry; writing heals.  Writing improves working memory, learning, and coping skills. It improves social/linguistic behaviors and athleticism.  Writing connects with emotions and helps with cognitive processing and reorganizing.  In rewriting the ending with adapting words; personal meaning is enhanced; a new sense of the experience is discovered. Writing settles feelings that arise from life “challenges”. It helps one make sense of the experience, the “whole”. Words help one adapt personal meaning.  With writing, experiencing and sharing sometimes memories are sparked. New meaning is found, sometimes with a “narrative” attitude.  When stories are renewed, hope is fostered by tapping into one’s own capacity to make life changes (Berger, R., & McLeod, J., 2006).  Power found after life challenges are resiliency supportive.    In Writing the Roller Coasters we will explore the benefits of writing for health.  Participants will experience the Pennebaker Process. We will discuss the impact and importance of timing in writing.  We will discover how writing supports action orientated self-care.  The RES process: Reflective, Expressive and Symbolic processes of poetry therapy will be explored, along with how poetry heals.  Participants will participate in a group writing process, which is health supportive.

Shari Liesch,  MSN, APNP

5B: Endocrine Case Studies

Case Study 1: A Twisted Tale of Diagnosis: Multiple Endocrine Conditions and New Diabetes
Discuss a case where the presentation of diabetes suggested one type of diabetes and a syndrome, but the team found that the case was much more complicated!  

Case Study 2: Presentation, Evaluation, and Treatment of a 15-year-old Male with Untreated, Simple-Virilizing CAH
This case report describes a 15 year old male presenting to an outpatient pediatric endocrinology clinic for evaluation for short stature.  Short stature refers to height more than two standard deviations below the mean for a child’s age and sex and also includes children who are more than two standard deviations below mid-parental target height.  Referral for short stature is common, and evaluation includes screening for pathological causes of growth failure and genetic patterns of growth and puberty.  Endocrine causes of short stature include growth hormone deficiency, thyroid disease, and adrenal disorders.  Height is also largely influenced by timing and pace of puberty.  Children who have precocious puberty and adrenarche have an attenuated growth spurt which can result in short stature.  Congenital Adrenal Hyperplasia (CAH) refers to a group of inherited disorders caused by an enzyme deficiency, most commonly 21-hydroxylase deficiency.  Patients with 21-hydroxylase deficiency are unable to produce normal amounts of cortisol, so their cortisol synthesis pathway is shunted towards androgen production.  Early and excessive androgen production leads to premature epiphyseal fusion and consequential short stature.  The following case will discuss the presentation, evaluation, and management of untreated CAH in a teenage male.

Case Study 3: Variable Presentation of Hypophosphatasia among Two Siblings
I would like to discuss hypophosphatasia, an extremely rare metabolic bone disease that is rarely seen in a pediatric endocrine clinic and discuss treatment that had only been available for the past few years.  I will present a case study about a 13 year old male who presented to my clinic with short stature. Baseline labs were completed and revealed a low alkaline phosphatase, confirmed on repeat testing, serum phosphorus, calcium, PTH, as well as peak growth hormone after stimulation with arginine and clonidine were all normal. During that same time, his 2 year old brother was seen by multiple dentist for early loss of dentition. Labs obtained by his dentist that revealed a low alkaline phosphatase in his brother as well. Genetic testing was completed on both children and results were consistent with autosomal dominant hypophosphatasia. Both children will be starting treatment with Asfotase Alpha a human recombinant enzyme replacement enzyme.

Melissa Rearson, MSN, CRNP
Meredith Allen

Katherine Wargo, NP

Jennifer Seekford, APRN 

​​3:00 p.m. - 3:15 p.m.Refreshment Break
Coffee, Tea, Water and Soft Drinks Provided 
3:15 p.m. - 4:15​ p.m.
1.0 Contact Hour*
​Concurrent Session 6:
​6A: Endocrine Overview Part 2

This session emphasizes Adrenal and Bone Metabolism Disorders and will be of use to both the New and the experienced pediatric endocrine nurse. 

Adrenal conditions discussed:
  • Cushing Syndrome
  • Aldosteronism
  • Adrenal androgen excess
  • Feminizing tumors
Bone Metabolism disorders discussed:
  • Hypoparathyroidism
  • Hyperparathyroidism
  • Pseudohypoparathyroidism
  • Vitamin D disorders
  • Calcium disorders

Fran Waite, RN

​6B:  Bringing Evidence into Practice for Improving Transitional Care: Demystifying Implementation

This presentation provides an overview approaches to implementation for improving transitional care. Session participants will be able to:
  • Describe the key stakeholders in transitional care.
  • Identify the components and relevance of implementation science for a quality improvement project.
  • Analyze stumbling blocks to implementation based on a transitional care case study.​
Andrew Dwyer, PhD, FNP-BC, FNAP

4:20 p.m. - 5:20 p.m.​
1.0 Contact Hour*

General Session 6
What's Sex Got to Do With It? Providing Competent Care for LGBTQ+ Youth and Their Families
Pediatric and adolescent transgender care is typically embedded in pediatric endocrinology practices. We want all pediatric endocrinology providers, including NPs and RNs, to be able to provide inclusive and affirming care for LGBTQ+ children, adolescents, and their families. The presenters will define gender terms and how to affirm gender expansive children and teens. They will present some patient-care scenarios involving LGBTQ+ youth/families, and solicit audience participation. They will also present several options for GnRH agonist ("blocker") therapy and gender affirming hormone therapy, and discuss the pharmacology of the most commonly used medications in our clinic. The presenters feel that the information they are presenting is unique because they are part of the only pediatric transgender clinic of its kind within a 250+ mile radius. Coming from the center of the midwest, the center provides "progressive" care in a region that isn't always progressive. The presenters will include humor, encourage audience participation, and bring a special flair to their presentation.​

Casey Lofquest, MSN, RN, CPNP
Karen Hamon, BSN, RN
Jamie Reed, BA, CM
​5:​30 p.m. - 6:30 p.m. Committee Meetings: Education, Research, Nominations, Conference Planning
7:00 p.m. - 10:00 p.m. Evening Event

Thursday, November 5, 2020
​Time Presentation/Event​ Presenter(s)
7:45 a.m. - 8:00 a.m.

8:00 a.m. - 9:00 a.m.
1.0 Contact Hour*
New Member/First-Time Attendee Feedback Session
Be first in line for breakfast and provide some feedback to the PENS leadership about your first impressions of the PENS National Conference. This is a roundtable discussion to gather data from new members and first-time a​ttendees.

General Session 7 and Breakfast
Urologic Issues in Boys and Girls with CAH

Dr. Palmer will discuss various urologic concerns for children and adolescents diagnosed with CAH.

Board of Directors and Conference Planning Committee

Blake Palmer, MD
9:00 a.m. - 10:00 a.m.​
1.0 Contact Hour*
​General Session 8 
Thinking Outside of the Box to Reach into the Community: Using the Internet and Social Media in the Diabetes Center to Connect Families and Provide Education

Over the years, I have worked with a team at our Diabetes Center to try and find ways to connect without patients outside of our usual clinic visits. Diabetes is a difficult condition and families often feel alone in managing day in and day out. I will share with PENS participants ways in which we have successfully reached out to our families in the community where they are by using internet resources such as newly designed web pages, e-newsletters and most importantly social media.  I will share my experience with using social media to connect with families in a way that provides connections within the community (families connecting with each other) and also provides timely education--for example Facebook posts for families preparing for a weather emergency TONIGHT!  We have worked hard to think outside of the box to find ways to provide information, educational resources, and very welcome positive reassurance to our families and their response has been overwhelming! This session will inspire the listener to think differently about ways that their team can connect with families to disseminate information and to give families a forum to connect with and inspire each other!  This type of presentation will be different for PENS participants as it will inspire the listener's creativity and will encourage team members to work together to think through new ways to connect with patients and families.

Melissa Rearson, MSN/CRNP

10:00 a.m. - 10:15 a.m. ​Refreshment Break
Coffee, Tea, Water and Soft Drinks Provided 
10:15 a.m. - 11:15 a.m.
1.0 Contact Hour*
​General Session 9:
Diabetes Distress: Overview, Assessment of, and Assessing in Clinical Care

Diabetes distress is about the emotional side of caring for self with diabetes.  About one third of youth with diabetes experience diabetes distress (DD) (Fischer, L. et al 2019). This session will define DD, review assessment of DD and risk factors for DD.  While DD is best managed in a multidisciplinary fashion, this is not always available.  Recent data demonstrates DD can be addressed in the clinic visit (Fischer, 2019).  Fischer listed strategies to consider in DD interventions will be reviewed, including:  

  • Focus on feelings, beliefs, expectations; 
  • Help gain perspective; 
  • Help develop a concrete plan; and 
  • Discuss follow up plan.

Small group discussion using case scenarios will be used as participants practice using DD interventions as outlined above, (Fisher, et al., 2019).   

Shari Liesch, MSN, APNP
​11:15 a.m. ​Closing RemarksCatherine Flynn, RN, MSN, APRN, CDE
* Subject to change based upon approval 
Total number of contact hours applied for is 21.0 (17.25 for the regular conference plus 3.75 for the pre-conference workshop)